引用本文:杨淑凤,张卓然,李岩,奥察玛.CpG ODN 对卵清蛋白致敏的哮喘小鼠模型的免疫调节作用研究[J].大连医科大学学报,2005,27(2):88-90.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 次   下载 本文二维码信息
码上扫一扫!
分享到: 微信 更多
CpG ODN 对卵清蛋白致敏的哮喘小鼠模型的免疫调节作用研究
杨淑凤, 张卓然, 李岩, 奥察玛
大连医科大学 微生物学教研室,辽宁 大连 116027
摘要:
[目的] 研究寡核苷酸免疫刺激序列CpG ODN(CpG Oligodeoxyneucleotide)对卵清蛋白(OVA)致敏哮喘小鼠的免疫调节作用,探讨哮喘的非激素治疗方法。[方法]以OVA免疫BALB/c小鼠,致敏前和致敏阶段腹腔注射CpG ODN,分别用地塞米松和生理盐水作为激素治疗组和哮喘对照组。 流式细胞仪检测各组哮喘小鼠的外周血T淋巴细胞亚群;ELISA法检测各组小鼠血清IL-4,IFN-γ,Ig-E水平;HE染色观察各组哮喘小鼠肺组织病理变化。[结果] 与哮喘对照组相比,CpG组能明显降低血清IL-4水平,NS组:(106.97±13.40) pg/mL, CpG组: (87.69±13.25) pg/mL;降低血清Ig-E水平,NS组:(4.78±1.65) IU/mL,CpG组:(3.52±0.23)IU/mL(P<0.05);增加血清IFN-γ含量,NS组: (34.76±1.51)pg/mL, CpG组: (49.93±9.18)pg/mL(P<0.05);上调CD4/CD8的比值,NS组:(3.53±0.37),CpG组:(3.73±0.55)(P<0.05 );CpG组和地塞米松组均能抑制肺组织中嗜酸细胞的浸润(P<0.05)。[结论] CpG ODN能有效促进哮喘小鼠体内TH2反应向TH1反应,可作为哮喘的预防和治疗的非激素手段。
关键词:  CpG ODN  哮喘; 免疫调节
DOI:10.11724/jdmu.2005.02.04
分类号:R373.2
基金项目:
Effect of CpG oligodeoxynucleotides in OVA antigen induce allergic airway reaction in mice
YANG Shu-feng, ZHANG Zhuo-ran, LI Yan, Orchama
Department of Microbiology, Dalan Medical University,Dalian 116027, China
Abstract:
[Objective] To investigate the effect of CpG-motif oligodeoxy nucleotides (CpG ODN) on the antigen (OVA) induced allergic airway reaction in mice. [Methods] The asthma model was set up in the BALB/c mice with OVA, Before the antigen insensitization stage, CpG ODN、Anaflogistico and NS were used intra peritoneal. During the state of antigen insensitization, three groups did the same processing. [Results] Compared with the NS control, coadministration of CpG ODN insensitization phase significant reduced the serologic concentrations of IL-4, NS group:(106.97±13.40) pg/mL, CpG group: (87.69±13.25) pg/mL;reduce the serologic concentrations of Ig-E, NS group:(4.78±1.65) IU/mL,CpG group:(3.52±0.23) IU/mL(P<0.05)and increased of IFN-γ level in serum, NS group: (34.76±1.51) pg/mL, CpG group: (49.93±9.18) pg/mL (P<0.05). CpG ODN group updated the serologic CD4/CD8 ratio from (3.53±0.37) to (3.73±0.55)(P<0.05). Coadministration of CpG ODN also reduced the percent of EOS in lung tissue (P<0.05). [Conclusion] This study suggests that in-traperitoneal coadministration of CpG ODN enhances Th1 cytokine such as IL-4 and Ig-E expression, down-regulates Th2 cytokine (IFN-γ) expression. It plays an important role of immunomodulation on Th1/Th2. This study also suggests that CpG ODN immunization can be an effective non-hormone therapy for asthma.
Key words:  CpG oligodeoxynucleotides  asthma  immunotherapy